May. 12, 2011
Chongqing Zhifei Biological Products entered the auction for Bilthoven Biologicals, a Dutch company offering both vaccines and CMO services, bidding US$93 million. Bilthoven is a spinoff of the Netherlands Vaccine Institute. Its assets include sophisticated biological product equipment and several vaccine products. This non-binding offer expects confirmation from Bilthoven Biologicals before August 2011. Zhifei is a public company listed at the Shenzhen Stock Exchange with a market cap of 11 billion RMB.